FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sulfasalazine Tablets
Status: Currently in Shortage
»Date first posted: 04/24/2020
»Therapeutic Categories: Gastroenterology

Expand all

Chartwell Pharma (Reverified 09/14/2021)

Company Contact Information:
845-232-1683

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg tablets; Bottle of 100 (NDC 23155-019-01) Product being allocated. Distributed by Avet. For inquiries, call Customer Service number 1-855-228-9470 Other

Pfizer Pharmaceuticals (Reverified 09/09/2021)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 100 (NDC 0013-0101-10) Available Other
AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 300 (NDC 0013-0101-20/0013-0101-30) Next Delivery: October 2021; Estimated Recovery: TBD Other
AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 100 (NDC 0013-0102-50) Next Delivery and Estimated Recovery: October 2021 Other
AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 300 (NDC 0013-0102-20/0013-0102-60) Available Other
Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 100 (NDC 59762-0104-1/59762-0104-5) Next Delivery: November 2021; Estimated recovery: Q1 2022 Shortage per Manufacturer: Manufacturing Delay Other
Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 300 (NDC 59762-0104-6) Next Delivery: November 2021; Estimated recovery: Q1 2022 Shortage per Manufacturer: Manufacturing Delay Other
500 mg tablets; bottle of 100 (NDC 59762-5000-1/59762-5000-5) Next Delivery: October 2021; Estimated Recovery: Q1 2022 2021 Shortage per Manufacturer: Manufacturing Delay Other
500 mg tablets; bottle of 300 (NDC 59762-5000-6) Next Delivery: November 2021; Estimated recovery: Q1 2022 Shortage per Manufacturer: Manufacturing Delay Other

Teva Pharmaceuticals (Revised 09/20/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg 100 Count (NDC 00591-0796-01) Available This product is on allocation.
500 mg 1000 Count (NDC 00591-0796-10) Available This product is on allocation.
500 mg 500 Count (NDC 00591-0796-05) Available This product is on allocation.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English